Caicun Zhou

2.9k total citations
39 papers, 2.0k citations indexed

About

Caicun Zhou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Caicun Zhou has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Caicun Zhou's work include Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Caicun Zhou is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Lung Cancer Research Studies (21 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Caicun Zhou collaborates with scholars based in China, United States and Hungary. Caicun Zhou's co-authors include Fei Zhou, Xuefei Li, Tao Jiang, Shengxiang Ren, Chunxia Su, Meng Qiao, Chao Zhao, Xiaoxia Chen, Guanghui Gao and Huikang Xie and has published in prestigious journals such as Cancer, European Journal of Cancer and British Journal of Clinical Pharmacology.

In The Last Decade

Caicun Zhou

38 papers receiving 1.9k citations

Peers

Countries citing papers authored by Caicun Zhou

Since Specialization

Citations

This map shows the geographic impact of Caicun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caicun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caicun Zhou more than expected).

Fields of papers citing papers by Caicun Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caicun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caicun Zhou. The network helps show where Caicun Zhou may publish in the future.

Co-authorship network of co-authors of Caicun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Caicun Zhou. A scholar is included among the top collaborators of Caicun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caicun Zhou. Caicun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Heterogeneity in advanced pulmonary sarcomatoid carcinoma and its efficacy to immune checkpoint inhibitors 2024 ·European Journal of Cancer ·(unknown), Tianqing Chu, Xiaorong Dong, Huijuan Wang, Qian Chu, Xiuyu Cai, Jialei Wang, Yu Yao, Lin Wu, Feng Ye, Bo Zhu, Caicun Zhou, Chunxia Su	2
2	Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer 2021 ·Frontiers in Oncology ·Juan Zhou, Jing Zhao, Qingzhu Jia, Qian Chu, Fei Zhou, (unknown), Wencheng Zhao, Shengxiang Ren, Caicun Zhou, Chunxia Su	15
3	Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC 2021 ·Frontiers in Oncology ·(unknown), Fengying Wu, Xuefei Li, Chao Zhao, Yijun Jia, Keyi Jia, Ruoshuang Han, Meng Qiao, Wei Li, Jia Yu, Fei Zhou, Anwen Xiong, Bin Chen, Jue Fan, Shengxiang Ren, Caicun Zhou	29
4	The genomic and immunologic profiles of pure pulmonary sarcomatoid carcinoma in Chinese patients 2021 ·Lung Cancer ·Fei Zhou, Yan Huang, Weijing Cai, Jin Li, Chunxia Su, Shengxiang Ren, Chunyan Wu, Caicun Zhou	25
5	CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer 2021 ·Lung Cancer ·Qian Liu, Meng Qiao, Zoltán Lohinai, Shiqi Mao, Yingying Pan, Yan Wang, (unknown), Fei Zhou, Tao Jiang, Xianghua Yi, Shengxiang Ren, Caicun Zhou, Fred R. Hirsch	13
6	The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 2021 ·Frontiers in Oncology ·Haowei Wang, Fei Zhou, Meng Qiao, Xuefei Li, Chao Zhao, Lei Cheng, Xiaoxia Chen, Caicun Zhou	25
7	Folate receptor-positive circulating tumor cells as a predictive biomarker for the efficacy of first-line pemetrexed-based chemotherapy in patients with non-squamous non-small cell lung cancer 2020 ·Annals of Translational Medicine ·Xiaoxia Chen, Fei Zhou, Xuefei Li, Guohua Yang, Chao Zhao, (unknown), (unknown), Jia Yu, Guanghui Gao, Jiayu Li, Aiwu Li, Shengxiang Ren, Caicun Zhou	9
8	The cutting-edge progress of immune-checkpoint blockade in lung cancer 2020 ·Cellular and Molecular Immunology ·Fei Zhou, Meng Qiao, Caicun Zhou	149
9	Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors 2020 ·Lung Cancer ·(unknown), Jing Zhao, Juan Zhou, Fei Zhou, Tao Jiang, Sen Jiang, Xiwen Sun, Xiaofang You, Fengying Wu, Shengxiang Ren, Caicun Zhou, Chunxia Su	86
10	Clinical value of neutrophil-to-lymphocyte ratio in patients with non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors 2019 ·Lung Cancer ·Tao Jiang, Yuchen Bai, Fei Zhou, Wei Li, Guanghui Gao, Chunxia Su, Shengxiang Ren, Xiaoxia Chen, Caicun Zhou	73
11	Impact of clinicopathological features on the efficacy of immune checkpoint inhibitors plus conventional treatment in patients with advanced lung cancer 2019 ·Journal of Thoracic Disease ·Guanghui Gao, Meng Qiao, (unknown), Tao Jiang, Fei Zhou, Xuefei Li, Chao Zhao, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou	3
12	Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M 2018 ·Lung Cancer ·Sha Zhao, Xuefei Li, Chao Zhao, Tao Jiang, Yijun Jia, Jinpeng Shi, Yayi He, Jiayu Li, Fei Zhou, Guanghui Gao, Wěi Li, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou	34
13	A Phase II Clinical Trial of Apatinib in Pretreated Advanced Non-squamous Non–small-cell Lung Cancer 2018 ·Clinical Lung Cancer ·Fengying Wu, (unknown), Anwen Xiong, Guanghui Gao, Wěi Li, Weijing Cai, Chunxia Su, Xiaoxia Chen, Fei Zhou, Jing Zhao, Shengxiang Ren, Caicun Zhou	44
14	Novel Mutations on EGFR Leu792 Potentially Correlate to Acquired Resistance to Osimertinib in Advanced NSCLC 2017 ·Journal of Thoracic Oncology ·(unknown), Fei Zhou, Wenxiang Shen, Tao Jiang, Xue Wu, Xiaoling Tong, Yang Shao, Songbing Qin, Caicun Zhou	74
15	Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer 2017 ·Journal of Thoracic Oncology ·Xiaomei Gong, Xuefei Li, Tao Jiang, Huikang Xie, Zhengfei Zhu, Fei Zhou, Caicun Zhou	232
16	Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells? 2017 ·Lung Cancer ·Fei Zhou, Likun Hou, Ting Ding, (unknown), Xiaoxia Chen, Chunxia Su, (unknown), Guanghui Gao, Shengxiang Ren, Fengying Wu, Jiang Fan, Chunyan Wu, Jie Zhang, Caicun Zhou	16
17	Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancer 2017 ·Lung Cancer ·Xiaozhen Liu, Tao Jiang, (unknown), Xuefei Li, Chao Zhao, Jinpeng Shi, Sha Zhao, Yijun Jia, Meng Qiao, Limin Zhang, (unknown), Guanghui Gao, Fei Zhou, Fengying Wu, Xiaoxia Chen, Yayi He, Shengxiang Ren, Chunxia Su, Caicun Zhou	29
18	Effect of Combined Therapy Inhibiting EGFR and VEGFR Pathways in Non–Small-cell Lung Cancer on Progression-free and Overall Survival 2016 ·Clinical Lung Cancer ·Tao Jiang, Meng Qiao, Fei Zhou, Shengxiang Ren, Chunxia Su, Caicun Zhou	13
19	Folate Receptor–Positive Circulating Tumor Cell Detected by LT-PCR–Based Method as a Diagnostic Biomarker for Non–Small-Cell Lung Cancer 2015 ·Journal of Thoracic Oncology ·Xiaoxia Chen, Fei Zhou, Xuefei Li, Guohua Yang, Ling Zhang, Shengxiang Ren, Chao Zhao, Qinfang Deng, Wei Li, Guanghui Gao, Aiwu Li, Caicun Zhou	97
20	Genomic polymorphisms of SLC29A3 associated with overall survival in advanced non-small-cell lung cancer treated with gemcitabine 2014 ·Medical Oncology ·Xiaoxia Chen, Ling Zhang, Shengxiang Ren, Xuefei Li, Fei Zhou, Wěi Li, Guanghui Gao, Yayi He, Caicun Zhou	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact